Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
Lyophilized (Unreconstituted) Storage Before reconstitution, DSIP powder demonstrates excellent stability
These findings support the hypothesis that the experimental LC supplementation protocol is more effective than the traditional "classic" protocol in improving endurance performance through enhanced fat oxidation, more efficient cardiovascular function, and reduced perceived exertion
Blocking that enzyme, in the preclinical literature, appears to free up NAD+ and push adipocytes back toward burning energy instead of storing it
Pharmaceuticals , 16
